These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 34409919)

  • 1. Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review.
    Hassoun HK; Al-Mahadawi A; Sheaheed NM; Sami SM; Jamal A; Allebban Z
    Neurol Res; 2022 Jan; 44(1):14-23. PubMed ID: 34409919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CLINICO-EPIDEMIOLOGICAL STUDY OF MULTIPLE SCLEROSIS IN MOSUL CITY, IRAQ.
    Taher Y; Ahmed M; Majdal H
    Georgian Med News; 2023; (340-341):47-52. PubMed ID: 37805872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis in Iraq: does it have the same features encountered in Western countries?
    Al-Araji A; Mohammed AI
    J Neurol Sci; 2005 Jul; 234(1-2):67-71. PubMed ID: 15946690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological study of multiple sclerosis in La Rioja.
    Bártulos Iglesias M; Marzo Sola ME; Estrella Ruiz LA; Bravo Anguiano Y
    Neurologia; 2015; 30(9):552-60. PubMed ID: 24975346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of multiple sclerosis in Santiago de Compostela (Spain).
    Costa Arpín E; Naveiro Soneira J; Lema Bouzas M; González Quintela A; Prieto González JM
    Acta Neurol Scand; 2020 Sep; 142(3):267-274. PubMed ID: 32392359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis by phenotype in Germany.
    Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
    Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features of Late-Onset Multiple Sclerosis: a Systematic Review and Meta-analysis.
    Naseri A; Nasiri E; Sahraian MA; Daneshvar S; Talebi M
    Mult Scler Relat Disord; 2021 May; 50():102816. PubMed ID: 33571792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of patients with multiple sclerosis enrolled in a new registry in Egypt.
    Zakaria M; Zamzam DA; Abdel Hafeez MA; Swelam MS; Khater SS; Fahmy MF; Abdel Hady A; Fouad MM; Abdel Nasser A; Aref H; Gadallah M
    Mult Scler Relat Disord; 2016 Nov; 10():30-35. PubMed ID: 27919495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in symptoms of depression between females and males with relapsing-remitting multiple sclerosis.
    Mayo CD; Lacey C; Gawryluk JR;
    Mult Scler Relat Disord; 2021 Jun; 51():102884. PubMed ID: 33799287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological study of multiple sclerosis in the Illawarra region.
    Dal SR; Elphick TL; Fuller K
    Intern Med J; 2023 Jun; 53(6):1010-1017. PubMed ID: 35112760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and incidence of multiple sclerosis in Panama (2000-2005).
    Gracia F; Castillo LC; Benzadón A; Larreategui M; Villareal F; Triana E; Arango AC; Lee D; Pascale JM; Gomez E; Armien B
    Neuroepidemiology; 2009; 32(4):287-93. PubMed ID: 19246933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disability and prognosis of relapsing remitting multiple sclerosis, is it different in Iraqi patients?
    Hasan ZN
    Neurosciences (Riyadh); 2011 Jul; 16(3):233-6. PubMed ID: 21677613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Can J Neurol Sci; 2005 Feb; 32(1):37-42. PubMed ID: 15825544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology, characteristics and treatment of patients with relapsing remitting multiple sclerosis and incidence of high disease activity: Real world evidence based on German claims data.
    Ohlmeier C; Gothe H; Haas J; Osowski U; Weinhold C; Blauwitz S; Schmedt N; Galetzka W; Berkemeier F; Tackenberg B; Stangel M
    PLoS One; 2020; 15(5):e0231846. PubMed ID: 32357176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002.
    Tanaka K; Kujuro Y; Suzuki S; Tanahashi N; Hamada J; Nogawa S; Suzuki N
    Intern Med; 2005 Jun; 44(6):560-6. PubMed ID: 16020880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time interval between disease onset and MS diagnosis during the last decades in Latin America.
    Rojas JI; Carnero Contentti E; Henestroza P; Giachello S; Correale J
    Mult Scler Relat Disord; 2021 Feb; 48():102672. PubMed ID: 33338946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic and clinical profile of Multiple Sclerosis in Kashmir: A short report.
    Zahoor I; Asimi R; Haq E; Yousuf Wani I
    Mult Scler Relat Disord; 2017 Apr; 13():103-106. PubMed ID: 28427689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing age of multiple sclerosis onset from 1920 to 2022: a population-based study.
    Habbestad A; Willumsen JS; Aarseth JH; Grytten N; Midgard R; Wergeland S; Myhr KM; Torkildsen Ø
    J Neurol; 2024 Apr; 271(4):1610-1617. PubMed ID: 38097800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of Optic Neuritis among Omani Patients with Multiple Sclerosis at the Sultan Qaboos University Hospital, Muscat, Oman.
    Alkharusi F; Sabt B; Al-Mujaini AS
    Sultan Qaboos Univ Med J; 2023 Nov; 23(4):472-478. PubMed ID: 38090249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.